Cytarabine
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20233 publications
Response to Venetoclax and Azacitidine in Induction-Refractory Adult Acute Myeloid Leukemia with UBTF Tandem Duplication and Associated Aberrant Splicing: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: October 14, 2026
Study on the Mechanism of CDC20 Inducing Cytarabine Resistance in Acute Myeloid Leukemia Cells by Targeting Autophagy
Journal: Zhongguo shi yan xue ye xue za zhi
Published: September 28, 2026
Progressive Cauda Equina Syndrome: A Rare Neurotoxic Complication of Intrathecal Methotrexate and Cytarabine.
Journal: American journal of therapeutics
Published: September 18, 2026
Unmasking a Hidden Burden: Chemotherapy-Induced and Exacerbated Diabetes in Paediatric Cancer: A Report of Two Cases.
Journal: Nigerian medical journal : journal of the Nigeria Medical Association
Published: September 01, 2026
Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia.
Journal: NEJM evidence
Published: August 25, 2026
Dasatinib-induced cervicofacial oedema in chronic myeloid leukaemia blast crisis.
Journal: BMJ case reports
Published: August 19, 2026
Anthracycline-Free FLA-VEN with or Without Midostaurin in Newly Diagnosed Intermediate- and Adverse-Risk AML: A Single-Center Retrospective Study.
Journal: Cancers
Published: August 18, 2026
Ameliorative Effect of Lycopene and Capsaicinoid Glucoside in Acute Myeloid Leukemia.
Journal: Journal of biochemical and molecular toxicology
Published: August 18, 2026
Current and future therapies for acute myeloblastic leukemia.
Journal: Journal of hematology & oncology
Published: August 17, 2026
Cold Atmospheric Plasma Reduces Migration and Viability of Oral Squamous Cell Carcinoma Cells and Increases E-Cadherin Expression.
Journal: Current issues in molecular biology
Published: August 13, 2026
Response to Comment on: "Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasiarelated changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin".
Journal: Haematologica
Published: August 12, 2026
Last Updated: 11/08/2026